SCHEMBL2518650

SCHEMBL2518650

[CH2]C(CCCCCCCCC)Oc1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 2/20 0.43
SLC6A4 P31645 2/20 0.41
MLNR O43193 1/20 0.41
NR1I2 O75469 1/20 0.41
ESR1 P03372 1/20 0.41
NR3C1 P04150 1/20 0.41
PGR P06401 1/20 0.41
ADRB2 P07550 1/20 0.41
CHRM2 P08172 1/20 0.41
ADRB1 P08588 1/20 0.41
HTR1A P08908 1/20 0.41
ADRA2A P08913 1/20 0.41
ADORA3 P0DMS8 1/20 0.41
CHRM1 P11229 1/20 0.41
DRD2 P14416 1/20 0.41
ADRA2B P18089 1/20 0.41
ADRA2C P18825 1/20 0.41
CHRM3 P20309 1/20 0.41
MAOA P21397 1/20 0.41
CNR1 P21554 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11319699 1.00 LTA4H (0.43) LTA4HSLC6A4MLNRNR1I2ESR1
SCHEMBL8554246 1.00 LTA4H (0.43) LTA4HSLC6A4MLNRNR1I2ESR1
SCHEMBL28177008 1.00 LTA4H (0.43) LTA4HSLC6A4MLNRNR1I2ESR1
Ammonia Solution, Strong SCHEMBL17311200 0.98 LTA4H (0.42) LTA4HSLC6A4MLNRNR1I2ESR1
SCHEMBL7976811 0.98 LTA4H (0.44) LTA4HSLC6A4MLNRNR1I2ESR1
SCHEMBL4635829 0.93 LTA4H (0.44) LTA4HSLC6A4MLNRNR1I2ESR1
SCHEMBL7350372 0.85 SLC6A4 (0.41) LTA4HSLC6A4ALDH1A1LMNASMN1; SMN2
SCHEMBL8887653 0.82 MMP13 (0.42) NR1I2SLC2A1
SCHEMBL18430836 0.81 LTA4H (0.46) LTA4HSLC6A4MLNRNR1I2ESR1
SCHEMBL6547814 0.81 LTA4H (0.46) LTA4HSLC6A4MLNRNR1I2ESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080132642-A1 treating a vulcanized rubber in a subdivided form in order to provide radically transferable atoms or groups on its surface; grafting at least one vinyl monomer to the surface treated vulcanized rubber in the presence of at least one transition metal compound PIRELLI & C S.P.A. (IT) 2008-06-05 US claimed
US-11940733-B2 Treatment device and treatment method FUJIFILM CORPORATION (JP) 2024-03-26 US disclosed
US-20240091127-A1 PHOTOCURABLE RESIN COMPOSITION FOR NAILS OR ARTIFICIAL NAILS, CURED PRODUCT, AND METHOD FOR COATING NAILS OR ARTIFICIAL NAILS THREEBOND CO., LTD. (JP) 2024-03-21 US disclosed
US-20220389129-A1 CURABLE COMPOSITION THREEBOND CO., LTD. (JP) 2022-12-08 US disclosed
EP-4067997-A1 PROCESSING DEVICE AND PROCESSING METHOD FUJIFILM Corporation (JP) 2022-10-05 EP disclosed
EP-4067394-A1 CURABLE COMPOSITION ThreeBond Co., Ltd. (JP) 2022-10-05 EP disclosed
US-11177478-B2 Crosslinked polymer binder from crosslinkable monomer for nonaqueous electrolyte secondary battery and use thereof TOAGOSEI CO. LTD. (JP) 2021-11-16 US disclosed
US-11072849-B2 Actinic-ray-curable coating material composition and layered product MITSUBISHI CHEMICAL CORPORATION (JP) 2021-07-27 US disclosed
EP-3605232-B1 TREATMENT METHOD AND TREATMENT DEVICE FUJIFILM CORP (JP) 2021-05-05 EP disclosed
US-10847837-B2 Binder for nonaqueous electrolyte secondary battery electrode, manufacturing method thereof, and use thereof TOAGOSEI CO. LTD. (JP) 2020-11-24 US disclosed
US-7427432-B2 Optical recording medium MITSUBISHI KAGAKU MEDIA CO., LTD. (JP) 2008-09-23 US disclosed
EP-1764794-A1 OPTICAL RECORDING MEDIUM Mitsubishi Kagaku Media Co., Ltd. (JP) 2007-03-21 EP disclosed
US-20060194017-A1 Optical recording medium MITSUBISHI KAGAKU MEDIA CO. LTD. (JP) 2006-08-31 US disclosed
US-7026369-B2 Aqueous emulsion composition and adherent composition MITSUI TAKEDA CHEMICALS, INC. (JP) 2006-04-11 US disclosed
EP-1283251-B1 Aqueous emulsion compositon and adherent composition MITSUI TAKEDA CHEMICALS INC (JP) 2004-04-21 EP disclosed
US-6548605-B1 Carboxyl modified saponified ethylene-vinyl acetate copolymer and surfactant; bonding strength; plastic sheets, films, and foams; fireproof MITSUI TAKEDA CHEMICALS INC. (JP) 2003-04-15 US disclosed
US-20030036581-A1 Aqueous emulsion composition and adherent composition MITSUI TAKEDA CHEMICALS, INC. (JP) 2003-02-20 US disclosed
EP-1283251-A2 Aqueous emulsion compositon and adherent composition MITSUI TAKEDA CHEMICALS, INC. (JP) 2003-02-12 EP disclosed
EP-1106628-A1 Aqueous emulsion composition and adherent composition Takeda Chemical Industries, Ltd. (JP) 2001-06-13 EP disclosed
US-4650000-A Acidizing method using microemulsion BEROL KEMI AB (SE) 1987-03-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240091127-A1 PHOTOCURABLE RESIN COMPOSITION FOR NAILS OR ARTIFICIAL NAILS, CURED PRODUCT, AND METHOD FOR COATING NAILS OR ARTIFICIAL NAILS POLR1C, NACA, ACR LTA4H 1640/4885SLC6A4 4644/4885MLNR 3869/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.